WallStreetZenWallStreetZen

NASDAQ: MSLE
Satellos Bioscience Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Satellos Bioscience earnings were -$24.9M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest MSLE earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MSLE reported annual earnings of -$24.9M, with 20.5% growth.

MSLE earnings history

Current Revenue
$0.0
Current Earnings
-$24.9M
Current Profit Margin
0%

MSLE Return on Equity

Current Company
-66.4%
Current Industry
-31.4%
Current Market
28.9%
MSLE's Return on Equity (-52%)... subscribe to Premium to read more.
High Return on Equity Performance

MSLE Return on Assets

Current Company
-60.2%
Current Industry
-9.6%
MSLE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MSLE announces earnings.

MSLE Return on Capital Employed

Current Company
-88.9%
Current Industry
-3.7%

MSLE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MSLE-$24.70M-$24.87MN/A-$1.70
CRDF-$44.95M-$45.88MN/A-$0.69
EDSA-$7.71M-$7.82MN/A-$1.15
KLRS-$43.98M-$44.10MN/A-$2.15
BMEA-$42.88M-$44.95MN/A-$0.68
View Top Biotech Stocks

Satellos Bioscience Earnings Reports & History FAQ

What were Satellos Bioscience's earnings last quarter?

Satellos Bioscience (NASDAQ: MSLE) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total MSLE earnings for the quarter were N/A. In the same quarter last year, Satellos Bioscience's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Satellos Bioscience stock.

Is Satellos Bioscience profitable or losing money?

As of the last Satellos Bioscience earnings report, Satellos Bioscience is currently losing money. Satellos Bioscience's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$24.87 million, a 20.54% increase year over year.

What was MSLE's earnings growth in the past year?

As of Satellos Bioscience's earnings date in Q2 2026, Satellos Bioscience's earnings has grown year over year. MSLE earnings in the past year totalled -$24.87 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.